Header Logo

Connection

ANTHONY MARESSO to Humans

Back to Details
This is a "connection" page, showing publications ANTHONY MARESSO has written about Humans.
ANTHONY MARESSO
Connection Strength
0.695
Humans
  1. Detection, persistence, and rising prevalence of oncogenic viruses revealed by wastewater metagenomics. Appl Environ Microbiol. 2026 06 17; 92(6):e0054726.
    View in: PubMed
    Score: 0.026
  2. Sewers to Solutions: A Guide to Wastewater Pathogen Monitoring. Annu Rev Med. 2026 Jan; 77(1):493-508.
    View in: PubMed
    Score: 0.025
  3. Results of TOR001: An open-label single patient study using targeted bacteriophage therapy for the treatment of chronic urinary tract infection. Int J Antimicrob Agents. 2025 Dec; 66(6):107613.
    View in: PubMed
    Score: 0.025
  4. Sequencing-Based Detection of Measles in Wastewater: Texas, January 2025. Am J Public Health. 2025 Jul; 115(7):1115-1119.
    View in: PubMed
    Score: 0.024
  5. Sequencing-Based Detection of Avian Influenza A(H5N1) Virus in Wastewater in Ten Cities. N Engl J Med. 2024 09 26; 391(12):1157-1159.
    View in: PubMed
    Score: 0.023
  6. Vaccines against extraintestinal pathogenic Escherichia coli (ExPEC): progress and challenges. Gut Microbes. 2024 Jan-Dec; 16(1):2359691.
    View in: PubMed
    Score: 0.023
  7. Progress toward a vaccine for extraintestinal pathogenic E. coli (ExPEC) II: efficacy of a toxin-autotransporter dual antigen approach. Infect Immun. 2024 05 07; 92(5):e0044023.
    View in: PubMed
    Score: 0.023
  8. The rise, fall, and resurgence of phage therapy for urinary tract infection. EcoSal Plus. 2024 12 12; 12(1):eesp00292023.
    View in: PubMed
    Score: 0.022
  9. Wastewater sequencing reveals community and variant dynamics of the collective human virome. Nat Commun. 2023 10 28; 14(1):6878.
    View in: PubMed
    Score: 0.022
  10. A Retrospective, Observational Study of 12 Cases of Expanded-Access Customized Phage Therapy: Production, Characteristics, and Clinical Outcomes. Clin Infect Dis. 2023 10 13; 77(8):1079-1091.
    View in: PubMed
    Score: 0.022
  11. Class-Driven Synergy and Antagonism between a Pseudomonas Phage and Antibiotics. Infect Immun. 2023 08 16; 91(8):e0006523.
    View in: PubMed
    Score: 0.022
  12. Effect of various types of extracellular DNA on V. hyugaensis biofilm formation. mSphere. 2023 08 24; 8(4):e0003523.
    View in: PubMed
    Score: 0.021
  13. Wastewater pandemic preparedness: Toward an end-to-end pathogen monitoring program. Front Public Health. 2023; 11:1137881.
    View in: PubMed
    Score: 0.021
  14. Broad protective vaccination against systemic Escherichia coli with autotransporter antigens. PLoS Pathog. 2023 02; 19(2):e1011082.
    View in: PubMed
    Score: 0.021
  15. Phage Therapy Related Microbial Succession Associated with Successful Clinical Outcome for a Recurrent Urinary Tract Infection. Viruses. 2021 10 12; 13(10).
    View in: PubMed
    Score: 0.019
  16. Loss of Dihydroxyacid Dehydratase Induces Auxotrophy in Bacillus anthracis. J Bacteriol. 2021 11 19; 203(24):e0041521.
    View in: PubMed
    Score: 0.019
  17. Antiviral Resistance and Phage Counter Adaptation to Antibiotic-Resistant Extraintestinal Pathogenic Escherichia coli. mBio. 2021 04 27; 12(2).
    View in: PubMed
    Score: 0.018
  18. Targeting of Mammalian Glycans Enhances Phage Predation in the Gastrointestinal Tract. mBio. 2021 02 09; 12(1).
    View in: PubMed
    Score: 0.018
  19. Phage-Antibiotic Synergy Is Driven by a Unique Combination of Antibacterial Mechanism of Action and Stoichiometry. mBio. 2020 08 04; 11(4).
    View in: PubMed
    Score: 0.018
  20. Progress towards the Development of a NEAT Vaccine for Anthrax II: Immunogen Specificity and Alum Effectiveness in an Inhalational Model. Infect Immun. 2020 07 21; 88(8).
    View in: PubMed
    Score: 0.018
  21. Heme catabolism in the causative agent of anthrax. Mol Microbiol. 2019 08; 112(2):515-531.
    View in: PubMed
    Score: 0.016
  22. Human Intestinal Enteroids for the Study of Bacterial Adherence, Invasion, and Translocation. Curr Protoc Microbiol. 2018 08; 50(1):e55.
    View in: PubMed
    Score: 0.015
  23. Novel Segment- and Host-Specific Patterns of Enteroaggregative Escherichia coli Adherence to Human Intestinal Enteroids. mBio. 2018 02 20; 9(1).
    View in: PubMed
    Score: 0.015
  24. Role for FimH in Extraintestinal Pathogenic Escherichia coli Invasion and Translocation through the Intestinal Epithelium. Infect Immun. 2017 11; 85(11).
    View in: PubMed
    Score: 0.014
  25. Bacteriophages from ExPEC Reservoirs Kill Pandemic Multidrug-Resistant Strains of Clonal Group ST131 in Animal Models of Bacteremia. Sci Rep. 2017 04 12; 7:46151.
    View in: PubMed
    Score: 0.014
  26. Iron and zinc exploitation during bacterial pathogenesis. Metallomics. 2015 Dec; 7(12):1541-54.
    View in: PubMed
    Score: 0.013
  27. Murine model of chemotherapy-induced extraintestinal pathogenic Escherichia coli translocation. Infect Immun. 2015 Aug; 83(8):3243-56.
    View in: PubMed
    Score: 0.012
  28. Bacillus anthracis Overcomes an Amino Acid Auxotrophy by Cleaving Host Serum Proteins. J Bacteriol. 2015 Jul; 197(14):2400-11.
    View in: PubMed
    Score: 0.012
  29. A product of heme catabolism modulates bacterial function and survival. PLoS Pathog. 2013; 9(7):e1003507.
    View in: PubMed
    Score: 0.011
  30. The theft of host heme by Gram-positive pathogenic bacteria. Metallomics. 2011 Aug; 3(8):788-96.
    View in: PubMed
    Score: 0.009
  31. Bacillus anthracis secretes proteins that mediate heme acquisition from hemoglobin. PLoS Pathog. 2008 Aug 22; 4(8):e1000132.
    View in: PubMed
    Score: 0.008
  32. Sortase as a target of anti-infective therapy. Pharmacol Rev. 2008 Mar; 60(1):128-41.
    View in: PubMed
    Score: 0.007
  33. Pseudomonas aeruginosa ExoS ADP-ribosyltransferase inhibits ERM phosphorylation. Cell Microbiol. 2007 Jan; 9(1):97-105.
    View in: PubMed
    Score: 0.007
  34. Wastewater Surveillance to Inform Cancer Epidemiology and Evidence-Based Interventions. Environ Sci Technol. 2026 Jun 16; 60(23):16390-16401.
    View in: PubMed
    Score: 0.007
  35. Bacteriophage-mediated reduction of uropathogenic E. coli from the urogenital epithelium. Infect Immun. 2026 Apr 15; 94(4):e0054325.
    View in: PubMed
    Score: 0.006
  36. Successful Bacteriophage Treatment of a Recalcitrant Intra-Abdominal Infection Caused by Multidrug-Resistant Pseudomonas aeruginosa in a 2-Year-Old Child. J Pediatr. 2026 Apr; 291:115005.
    View in: PubMed
    Score: 0.006
  37. Present and future of microbiome-targeting therapeutics. J Clin Invest. 2025 Jun 02; 135(11).
    View in: PubMed
    Score: 0.006
  38. Turning analysis into action: opportunities and challenges in implementing wastewater science for public health decision-making. Front Public Health. 2025; 13:1562659.
    View in: PubMed
    Score: 0.006
  39. Revealing patterns of SARS-CoV-2 variant emergence and evolution using RBD amplicon sequencing of wastewater. J Infect. 2024 Nov; 89(5):106284.
    View in: PubMed
    Score: 0.006
  40. Ezrin/radixin/moesin proteins are high affinity targets for ADP-ribosylation by Pseudomonas aeruginosa ExoS. J Biol Chem. 2004 Sep 10; 279(37):38402-8.
    View in: PubMed
    Score: 0.006
  41. Enterococcus faecalis-derived adenine enhances enterohaemorrhagic Escherichia coli Type 3 Secretion System-dependent virulence. Nat Microbiol. 2024 Sep; 9(9):2448-2461.
    View in: PubMed
    Score: 0.006
  42. Assessment of a SARS-CoV-2 wastewater monitoring program in El Paso, Texas, from November 2020 to June 2022. Int J Environ Health Res. 2024 Jan; 34(1):564-574.
    View in: PubMed
    Score: 0.005
  43. Phage Resistance Accompanies Reduced Fitness of Uropathogenic Escherichia coli in the Urinary Environment. mSphere. 2022 08 31; 7(4):e0034522.
    View in: PubMed
    Score: 0.005
  44. Interactions between Enterohemorrhagic Escherichia coli (EHEC) and Gut Commensals at the Interface of Human Colonoids. mBio. 2022 06 28; 13(3):e0132122.
    View in: PubMed
    Score: 0.005
  45. Considerations for the Use of Phage Therapy in Clinical Practice. Antimicrob Agents Chemother. 2022 03 15; 66(3):e0207121.
    View in: PubMed
    Score: 0.005
  46. Identifying Causative Microorganisms in Left Ventricular Assist Device Infections as a Guide for Developing Bacteriophage Therapy. J Surg Res. 2022 03; 271:73-81.
    View in: PubMed
    Score: 0.005
  47. Drivers of transcriptional variance in human intestinal epithelial organoids. Physiol Genomics. 2021 11 01; 53(11):486-508.
    View in: PubMed
    Score: 0.005
  48. Effect of substrate stiffness on human intestinal enteroids' infectivity by enteroaggregative Escherichia coli. Acta Biomater. 2021 09 15; 132:245-259.
    View in: PubMed
    Score: 0.005
  49. Enteropathogenic Escherichia coli Infection in Cancer and Immunosuppressed Patients. Clin Infect Dis. 2021 05 18; 72(10):e620-e629.
    View in: PubMed
    Score: 0.005
  50. Evaluating recovery, cost, and throughput of different concentration methods for SARS-CoV-2 wastewater-based epidemiology. Water Res. 2021 Jun 01; 197:117043.
    View in: PubMed
    Score: 0.005
  51. The Human Nose Organoid Respiratory Virus Model: an Ex Vivo Human Challenge Model To Study Respiratory Syncytial Virus (RSV) and Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Pathogenesis and Evaluate Therapeutics. mBio. 2021 02 22; 13(1):e0351121.
    View in: PubMed
    Score: 0.005
  52. A Millifluidic Perfusion Cassette for Studying the Pathogenesis of Enteric Infections Using Ex-Vivo Organoids. Ann Biomed Eng. 2021 Apr; 49(4):1233-1244.
    View in: PubMed
    Score: 0.005
  53. Enteroaggregative E. coli Adherence to Human Heparan Sulfate Proteoglycans Drives Segment and Host Specific Responses to Infection. PLoS Pathog. 2020 09; 16(9):e1008851.
    View in: PubMed
    Score: 0.004
  54. Human Intestinal Enteroids as a Model System of Shigella Pathogenesis. Infect Immun. 2019 04; 87(4).
    View in: PubMed
    Score: 0.004
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.